A non-randomised, single-centre comparison of induction chemotherapy followed by radiochemotherapy versus concomitant chemotherapy with hyperfractionated radiotherapy in inoperable head and neck carcinomas
2006

Comparing Chemotherapy Approaches for Head and Neck Cancer

Sample size: 122 publication Evidence: moderate

Author Information

Author(s): Graf Reinhold, Hildebrandt Bert, Tilly Wolfgang, Riess Hanno, Felix Roland, Budach Volker, Wust Peter

Primary Institution: Charité Medical School

Hypothesis

Does concomitant chemotherapy with radiotherapy provide better outcomes than induction chemotherapy followed by radiotherapy in patients with inoperable head and neck carcinomas?

Conclusion

Concurrent chemotherapy seemed more effective in treating head and neck tumors than induction chemotherapy followed by chemoradiation, resulting in better local control and a trend towards improved survival.

Supporting Evidence

  • Patients treated with the concomitant protocol had a significantly higher mean radiation dose compared to those in the sequential group.
  • The response rates for primary tumors were 90% in the concomitant group compared to 67% in the sequential group.
  • Local control rates were significantly higher in the concomitant group (41%) compared to the sequential group (17.6%).
  • Overall survival rates showed a trend in favor of the concomitant group, although not statistically significant.

Takeaway

This study looked at two ways to treat patients with hard-to-treat head and neck cancers. It found that giving chemotherapy at the same time as radiation works better than giving chemotherapy first and then radiation.

Methodology

The study compared two treatment protocols: a sequential protocol with induction chemotherapy followed by radiotherapy and a concomitant protocol with chemotherapy and radiotherapy given together.

Potential Biases

Potential biases may arise from the non-randomised design and the differences in treatment protocols.

Limitations

The study was non-randomised and conducted at a single center, which may limit the generalizability of the results.

Participant Demographics

Patients had unresectable stage IV head and neck cancer, with a comparable distribution of age, gender, and performance status across treatment groups.

Statistical Information

P-Value

p = 0.00

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-6-30

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication